Details of the Drug

General Information of Drug (ID: DMFY63O)

• Drug Name: Posoleucel
• Synonyms: ALVR105

Indication

Disease Entry	ICD 11	Status	REF
Hemorrhagic cystitis	GC00.1	Phase 3	[1]

• Drug Type: Cell therapy
• Cross-matching ID:
  DrugBank ID: DB17974
  TTD ID: DU4S5D

References

• [1] ClinicalTrials.gov (NCT04390113) Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT). U.S.National Institutes of Health.